相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CircEXOC6B Suppresses the Proliferation and Motility and Sensitizes Ovarian Cancer Cells to Paclitaxel Through miR-376c-3p/FOXO3 Axis
Yingchun Zheng et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2022)
Oncogenic role of MIR516A in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy
Honglei Jin et al.
AUTOPHAGY (2021)
MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma
Ronja-Melinda Komoll et al.
JOURNAL OF HEPATOLOGY (2021)
piRNA-30473 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in DLBCL
Huiying Han et al.
BLOOD (2021)
Functions of PIWI Proteins in Gene Regulation: New Arrows Added to the piRNA Quiver
Anne Ramat et al.
TRENDS IN GENETICS (2021)
Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation
Zhi Zeng et al.
CIRCULATION (2021)
Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer
M. Chiappa et al.
DRUG RESISTANCE UPDATES (2021)
Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis
Junjie Cen et al.
MOLECULAR CANCER (2021)
Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1
Shan Xing et al.
MOLECULAR CANCER (2021)
Gene regulation by long non-coding RNAs and its biological functions
Luisa Statello et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
AUF1 ligand circPCNX reduces cell proliferation by competing with p21 mRNA to increase p21 production
Dimitrios Tsitsipatis et al.
NUCLEIC ACIDS RESEARCH (2021)
NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration
Chunhong Cui et al.
ONCOGENE (2021)
LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis
Ke Wang et al.
ONCOTARGETS AND THERAPY (2021)
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity
Botai Li et al.
NATURE COMMUNICATIONS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The miR-181a-SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer
Anil Belur Nagaraj et al.
CANCER RESEARCH (2021)
Ovarian Cancer, Version 2.2020
Deborah K. Armstrong et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer
Ya Fan et al.
MOLECULAR CANCER (2021)
CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing
Peng Shen et al.
MOLECULAR CANCER (2021)
MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/fl-catenin in serous ovarian cancers
Yue Sun et al.
TRANSLATIONAL ONCOLOGY (2021)
Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation
Yuhao Luo et al.
AUTOPHAGY (2021)
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Xiaolin Wang et al.
GUT (2021)
MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer
Chia-Hao Tung et al.
ONCOGENE (2020)
SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a
Huilong Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB
Zhen Zhang et al.
CANCER LETTERS (2020)
Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis
Ziqian Sun et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET
Pan Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
Sandra Munoz-Galvan et al.
MOLECULAR CANCER (2020)
Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1
Xiaohong Hong et al.
MOLECULAR CANCER (2020)
Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
De-Ying Wang et al.
CANCER RESEARCH AND TREATMENT (2020)
circRNA-AKT1 Sequesters miR-942-5p to Upregulate AKT1 and Promote Cervical Cancer Progression
Rongying Ou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
circCELSR1 (hsa-circ-0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252
Shu Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
被撤回的出版物: Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma (Retracted article. See vol. 533, 2022)
Chenyu Ding et al.
CANCER LETTERS (2020)
Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/β-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy
Zhuofei Bi et al.
ADVANCED SCIENCE (2020)
NEAT1 Knockdown Suppresses the Cisplatin Resistance in Ovarian Cancer by Regulating miR-770-5p/PARP1 Axis
Mingzhe Zhu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
William P. Tew et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling
Wen-Xi Tan et al.
SCIENTIFIC REPORTS (2020)
Circular RNA circTNPO3 Regulates Paclitaxel Resistance of Ovarian Cancer Cells by miR-1299/NEK2 Signaling Pathway
Bing Xia et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Downregulation of circNRIP I Suppresses the Paclitaxel Resistance of Ovarian Cancer via Regulating the miR-2 I I-5p/HOXC8 Axis
Meng Li et al.
CANCER MANAGEMENT AND RESEARCH (2020)
被撤回的出版物: LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis (Retracted article. See vol. 14, pg. 3457, 2022)
Yuqin Wang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation
Liang-Yan Chen et al.
MOLECULAR CANCER (2020)
Knockdown of Circular RNA Hsa_circ_0000714 Can Regulate RAB17 by Sponging miR-370-3p to Reduce Paclitaxel Resistance of Ovarian Cancer Through CDK6/RB Pathway
Min Guo et al.
ONCOTARGETS AND THERAPY (2020)
Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells
Yanwei Luo et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2020)
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
Enrica Vescarelli et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
Jing Sun et al.
ONCOGENE (2019)
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes
Xiaodi Li et al.
BIOCHEMICAL PHARMACOLOGY (2019)
LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells
Mi Zhang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2019)
MicroRNA let-7d-5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1
Yan-Nan Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway
Zhuo-wei Gu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2019)
Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
Elizabeth L. Christie et al.
NATURE COMMUNICATIONS (2019)
MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells
Ga Bin Park et al.
NEOPLASIA (2019)
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Stephanie Lheureux et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
Xiaoxu Huang et al.
MOLECULAR CANCER (2019)
lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
Zewu Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression
Zhao Zhao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis
Xiaoran Long et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance
Yanyan Chen et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2019)
The biogenesis, biology and characterization of circular RNAs
Lasse S. Kristensen et al.
NATURE REVIEWS GENETICS (2019)
SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma
Peng-Fei Zhang et al.
AGING-US (2019)
The U1 spliceosomal RNA is recurrently mutated in multiple cancers
Shimin Shuai et al.
NATURE (2019)
MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor
Yingying Zhou et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy
Fan Liang et al.
ONCOGENESIS (2019)
Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27
Jing Jiang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
Hua Guo et al.
CANCER CELL INTERNATIONAL (2019)
Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer
Stacey J. Winham et al.
HUMAN MOLECULAR GENETICS (2019)
Overexpression of the lncRNA FER1L4 inhibits paclitaxel tolerance of ovarian cancer cells via the regulation of the MAPK signaling pathway
Siwei Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer
Takeshi Hisamatsu et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1
Mei Xu et al.
MOLECULAR CARCINOGENESIS (2019)
miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases
Jue Liu et al.
ONCOLOGY LETTERS (2019)
Long Noncoding RNA LINC01125 Enhances Cisplatin Sensitivity of Ovarian Cancer via miR-1972
Jia Guo et al.
MEDICAL SCIENCE MONITOR (2019)
Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis
Liuqing He et al.
THERANOSTICS (2019)
Valproic Acid Promotes Apoptosis and Cisplatin Sensitivity Through Downregulation of H19 Noncoding RNA in Ovarian A2780 Cells
Zahre Sajadpoor et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2018)
Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85
Di Wu et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis
Kyung Jin Eoh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis
Junrong Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway
Lin Bai et al.
EXPERIMENTAL CELL RESEARCH (2018)
miR-149-5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway
Manman Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2
Bairong Xia et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2018)
MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer
Sha Xiao et al.
MOLECULAR GENETICS AND GENOMICS (2018)
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Chun-Ming Wong et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer
Raul Garcia-Vazquez et al.
ONCOLOGY REPORTS (2018)
miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8
Yajie Cui et al.
ONCOLOGY REPORTS (2018)
miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1
Yanan Wang et al.
CELL DEATH & DISEASE (2018)
Endosomal Escape of ASOs Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation
Colton M. Miller et al.
NUCLEIC ACID THERAPEUTICS (2018)
Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas
Khyati Meghani et al.
CELL REPORTS (2018)
MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2
Ruonan Liu et al.
CANCER MEDICINE (2018)
STAT3 regulated miR-216a promotes ovarian cancer proliferation and cisplatin resistance
Pengfei Jin et al.
BIOSCIENCE REPORTS (2018)
The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation
Hao Wang et al.
CELL DEATH & DISEASE (2018)
miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer
Meina Yan et al.
CELL DEATH & DISEASE (2018)
LINC01118 Modulates Paclitaxel Resistance of Epithelial Ovarian Cancer by Regulating miR-134/ABCC1
Cong Shi et al.
MEDICAL SCIENCE MONITOR (2018)
miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells
Xiaoyan Shi et al.
FRONTIERS IN GENETICS (2018)
MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
Lanqin Cao et al.
BMB REPORTS (2018)
SLC27A2 regulates miR-411 to affect chemo-resistance in ovarian cancer
F. D. Chen et al.
NEOPLASMA (2018)
Comprehensive characterization of tissue-specific circular RNAs in the human and mouse genomes
Siyu Xia et al.
BRIEFINGS IN BIOINFORMATICS (2017)
microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP
Xiaodi Li et al.
BRITISH JOURNAL OF CANCER (2017)
A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel
Jinhua Zhou et al.
CLINICAL CANCER RESEARCH (2017)
Long non-coding RNA ENST00000457645 reverses cisplatin resistance in CP70 ovarian cancer cells
H. Yan et al.
GENETICS AND MOLECULAR RESEARCH (2017)
MicroRNA-146a-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes
Xiaodi Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
A map of human circular RNAs in clinically relevant tissues
Philipp G. Maass et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis
Celia S. L. Mak et al.
MOLECULAR CANCER (2017)
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Peter M. Bruno et al.
NATURE MEDICINE (2017)
LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
Jihong An et al.
ONCOTARGETS AND THERAPY (2017)
MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line
Yankun Liu et al.
ONCOLOGY LETTERS (2017)
MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression
Wen-Ting Chen et al.
JOURNAL OF OVARIAN RESEARCH (2017)
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
Man Xiao et al.
JOURNAL OF OVARIAN RESEARCH (2017)
Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression
Yuao Deng et al.
JOURNAL OF OVARIAN RESEARCH (2017)
miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
S-L Tung et al.
ONCOGENESIS (2017)
Restoration of microRNA-708 sensitizes ovarian cancer cells to cisplatin via IGF2BP1/Akt pathway
Xuying Qin et al.
CELL BIOLOGY INTERNATIONAL (2017)
Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition
George E. Duran et al.
BRITISH JOURNAL OF CANCER (2017)
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis
Ryan J. Hartmaier et al.
CANCER RESEARCH (2017)
The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer
Min-Wei Chen et al.
CANCER RESEARCH (2017)
Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer
Jing Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3
Ju-Yeon Jeong et al.
CANCER LETTERS (2017)
miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis
Guanqun Ge et al.
ONCOLOGY REPORTS (2016)
Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells
Priya Samuel et al.
TUMOR BIOLOGY (2016)
Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer
Jing Li et al.
TUMOR BIOLOGY (2016)
Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer
Zhentong Wei et al.
MEDICAL ONCOLOGY (2016)
Unique features of long non-coding RNA biogenesis and function
Jeffrey J. Quinn et al.
NATURE REVIEWS GENETICS (2016)
NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
A. R. Ozes et al.
ONCOGENE (2016)
PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells
Noemi Arrighetti et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1
Di-di Wu et al.
TUMOR BIOLOGY (2016)
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
Chi Lam Au Yeung et al.
NATURE COMMUNICATIONS (2016)
Protein tyrosine phosphatase PTPN3 promotes drug resistance and stem cell-like characteristics in ovarian cancer
Shuqin Li et al.
SCIENTIFIC REPORTS (2016)
The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer
Zhi-Guo Zheng et al.
SCIENTIFIC REPORTS (2016)
Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer
Young Eun Choi et al.
CELL REPORTS (2016)
HOTAIR is a potential target for the treatment of cisplatin-resistant ovarian cancer
Yu Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
The Noncoding RNA Revolution-Trashing Old Rules to Forge New Ones
Thomas R. Cech et al.
CELL (2014)
Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer
Jun-jun Qiu et al.
GYNECOLOGIC ONCOLOGY (2014)
circRNA Biogenesis Competes with Pre-mRNA Splicing
Reut Ashwal-Fluss et al.
MOLECULAR CELL (2014)
Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma
Henan Zhao et al.
ONCOLOGY REPORTS (2014)
Circular RNAs are a large class of animal RNAs with regulatory potency
Sebastian Memczak et al.
NATURE (2013)
Cell-Type Specific Features of Circular RNA Expression
Julia Salzman et al.
PLOS GENETICS (2013)
SIK2 Is a Centrosome Kinase Required for Bipolar Mitotic Spindle Formation that Provides a Potential Target for Therapy in Ovarian Cancer
Ahmed Ashour Ahmed et al.
CANCER CELL (2010)
Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair
Timothy D. Wiltshire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
分享论文
